Apoletto’s Twist Bioscience TWST Stock Holding History

Apoletto’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-454,856	Closed	-$10.5M	–	5
2019 Q1	$10.5M	Hold	454,856	–	–	9.29%	3
2018 Q4	$10.5M	Buy	+454,856	New	+$10.1M	13.97%	3

Other funds holding TWST

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Apoletto's TWST Position: Q2 2019 in Review

Apoletto sold out of Twist Bioscience (TWST) in Q2 2019, closing a stake of 454,856 shares — an estimated $10.5M sold.

Apoletto first reported a position in TWST in Q4 2018 and held it in 2 quarters. The position peaked at $10.5M in Q1 2019. 85 funds tracked by Wall St. Rank hold TWST as of Q2 2019.

Apoletto reported no remaining Twist Bioscience position as of Q2 2019 after selling out during the quarter.
Apoletto sold 454,856 Twist Bioscience shares in Q2 2019, an estimated $10.5M.
Apoletto first reported a position in Twist Bioscience in Q4 2018 and held it in 2 quarters.
Apoletto's Twist Bioscience position peaked at $10.5M in Q1 2019.
85 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2019.

Based on Apoletto's 13F filing for Q2 2019, filed 14 Aug 2019.